Follow us on Twitter LinkedIn

  • “Thank you very much for you to invite me to your excellent conference. I enjoyed it very much”.
    (Huaizheng Peng, GM, China Medical System Holdings)
  • "The conference was a really interesting blend of top class panel discussions and presentations from eminent industry professionals. I enjoyed the informal setting which enabled a great two way interaction and came back with knowledge and good contacts."
    (Rahul Garella, Former Senior Vice President, Glenmark Generics Europe)
  • “Interesting presentations at an exciting location”.
    (Frank Grams,VP, Head Alliance Management and Business Transactions, Sanofi R&D)
  • “The congress ran smoothly and we couldn’t have been looked after any better. My colleague Elena found the day extremely interesting”
    (Ali Whittaker and Fiona Gardner, Pharmatelevision)
  • “It was a pleasure attending the WPLC 2014 in London. I very much enjoyed the panels during this informative and productive event. Congratulations on the excellent organization. WPLC is a great opportunity to exchange best practice and discuss strategic business development topics with world class organizations and high caliber executives”
    (Cristiano Musso, VP, Head Corporate Licensing, Grünenthal GmbH)
  • “Thanks for putting on such a great event! I found it very informative and look forward to attending again next year!”
    (Alex Barker, Business Development Director, GBI)
  • “It was a good conference, I enjoyed it”
    (Phil L'Huillier, Director Business Management, Cancer Research Technology Ltd)
  • “’World Pharma Licensing Congress 2014 is great event for Pharma business, the speakers were well known expert and have their word in Licensing field ,the networking opportunities during the event were very valuable”’
    (Gharib Amer, Managing Director, Suecal)
  • “Speakers were excellent and the fact that is attracted so many key stakeholders in pharma licensing meant that there were also excellent networking opportunities.”
    (Dr Angela Kukula, Director of Enterprise, The Institute of Cancer Research)
  • “An excellent platform to share EFPIA’s strategy for health and growth in Europe (#HealthyEU) with the pharmaceutical industry and stakeholders.”
    (Liam English, Communications Director, EFPIA)
Register For WPLC 2015

The World Pharma Licensing Congress
10th February 2015

WPLC 2014 Executive Report



World Pharma Licensing Congress 2015 is an exclusive private meeting that will bring together leading pharma licensing and business development executives, academia and industry associations to address the key industry challenges and the future of Pharma Industry at the London Stock Exchange.

Pharma and Biotech companies are in need of alternative methods and strategies to strengthen and fuel their IP portfolios whilst reducing costs, shortening timescale and maintaining quality and high returns on investment. The WPLC 2015 is designed to act as a platform for developing innovative strategies for the stimulation of industry growth.

Topics to be discussed include:

  • Creating robust and sustainable patent pipeline through M&A and Licensing
  • The main considerations for a successful market entry strategy
  • Competitive Differentiation in Emerging Markets: Minimising potential risks and enhancing profts
  • Identifying trends and drivers in pharmaceutical innovation and deal-making
  • The global threat of parallel importation and counterfeiting in the pharmaceutical industry
  • Open innovation and collaborative partnerships: Safeguarding your IP portfolio

WPLC 2014 breakdown of attendees by industry:

WPLC 2014 breakdown of attendees by job title:
WPLC 2015 - Partners
2015 Industry & Media Partners
WPLC 2014 Interviews

WPLC SUMMIT - 2015. Copyright 2015. All Rights Reserved